Voyager Therapeutics: Q1 Earnings Snapshot

Published: 2025-05-06 16:14:17 ET VYGR

Published on 05/06/2025 at 16:14

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $31 million in its first quarter.

On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 53 cents.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 35 cents per share.

The gene therapy company posted revenue of $6.5 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $19.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News